source
- Fulcrum Therapeutics cuts workforce, retaining only nine employees as layoffs hit 48 staffFulcrum Therapeutics announced a dramatic reduction in its staff, letting go of 48 of its 57 full‑time employees. The move leaves the company with just nine remaining workers, effectively turning i…
- Analysts warn that PD-1/VEGF bispecific drugs may be better suited for liver cancer than lung cancerMany drugmakers have poured billions into PD-1/VEGF bispecific antibodies after ivonescimab beat Keytruda in a 2024 lung‑cancer trial, sparking a wave of deals and development programs. A recent C…